nodes	percent_of_prediction	percent_of_DWPC	metapath
Cromoglicic acid—Dysuria—Fludarabine—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Cromoglicic acid—Neutropenia—Fludarabine—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00706	0.00706	CcSEcCtD
Cromoglicic acid—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.00703	0.00703	CcSEcCtD
Cromoglicic acid—Stomatitis—Fludarabine—lymphatic system cancer	0.00699	0.00699	CcSEcCtD
Cromoglicic acid—Epistaxis—Fludarabine—lymphatic system cancer	0.00676	0.00676	CcSEcCtD
Cromoglicic acid—Swelling—Carmustine—lymphatic system cancer	0.00675	0.00675	CcSEcCtD
Cromoglicic acid—Eye pain—Carmustine—lymphatic system cancer	0.0066	0.0066	CcSEcCtD
Cromoglicic acid—Hypoaesthesia—Fludarabine—lymphatic system cancer	0.00641	0.00641	CcSEcCtD
Cromoglicic acid—Pharyngitis—Fludarabine—lymphatic system cancer	0.00639	0.00639	CcSEcCtD
Cromoglicic acid—Swelling—Mitoxantrone—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Cromoglicic acid—Anaemia—Teniposide—lymphatic system cancer	0.00589	0.00589	CcSEcCtD
Cromoglicic acid—Bronchospasm—Bleomycin—lymphatic system cancer	0.0058	0.0058	CcSEcCtD
Cromoglicic acid—Pancytopenia—Bleomycin—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Cromoglicic acid—Liver disorder—Methotrexate—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Cromoglicic acid—Chest pain—Teniposide—lymphatic system cancer	0.00543	0.00543	CcSEcCtD
Cromoglicic acid—Oedema—Teniposide—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Cromoglicic acid—Anaemia—Fludarabine—lymphatic system cancer	0.00518	0.00518	CcSEcCtD
Cromoglicic acid—Dysphagia—Carmustine—lymphatic system cancer	0.00515	0.00515	CcSEcCtD
Cromoglicic acid—Stomatitis—Bleomycin—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Cromoglicic acid—Tachycardia—Teniposide—lymphatic system cancer	0.00508	0.00508	CcSEcCtD
Cromoglicic acid—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00506	0.00506	CcSEcCtD
Cromoglicic acid—Malaise—Fludarabine—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Cromoglicic acid—Cough—Fludarabine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Cromoglicic acid—Pancytopenia—Carmustine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Cromoglicic acid—Hypotension—Teniposide—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Cromoglicic acid—Convulsion—Fludarabine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Cromoglicic acid—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Cromoglicic acid—Neutropenia—Carmustine—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Cromoglicic acid—Myalgia—Fludarabine—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Cromoglicic acid—Arthralgia—Fludarabine—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Cromoglicic acid—Discomfort—Fludarabine—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Cromoglicic acid—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Cromoglicic acid—Pancytopenia—Vincristine—lymphatic system cancer	0.00467	0.00467	CcSEcCtD
Cromoglicic acid—Dyspnoea—Teniposide—lymphatic system cancer	0.00464	0.00464	CcSEcCtD
Cromoglicic acid—Dysuria—Vincristine—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Cromoglicic acid—Neutropenia—Vincristine—lymphatic system cancer	0.0046	0.0046	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Cromoglicic acid—Oedema—Fludarabine—lymphatic system cancer	0.00457	0.00457	CcSEcCtD
Cromoglicic acid—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Cromoglicic acid—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.0045	0.0045	CcSEcCtD
Cromoglicic acid—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Cromoglicic acid—Neutropenia—Mitoxantrone—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Cromoglicic acid—Stomatitis—Carmustine—lymphatic system cancer	0.00447	0.00447	CcSEcCtD
Cromoglicic acid—Rash—Mechlorethamine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Cromoglicic acid—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Cromoglicic acid—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Teniposide—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Cromoglicic acid—Stomatitis—Vincristine—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Cromoglicic acid—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00426	0.00426	CcSEcCtD
Cromoglicic acid—Musculoskeletal stiffness—Methotrexate—lymphatic system cancer	0.00424	0.00424	CcSEcCtD
Cromoglicic acid—Nausea—Mechlorethamine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Cromoglicic acid—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00416	0.00416	CcSEcCtD
Cromoglicic acid—Urticaria—Teniposide—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Cromoglicic acid—Glossitis—Methotrexate—lymphatic system cancer	0.00412	0.00412	CcSEcCtD
Cromoglicic acid—Body temperature increased—Teniposide—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Cromoglicic acid—Abdominal pain—Teniposide—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Cromoglicic acid—Erythema—Bleomycin—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Cromoglicic acid—Paraesthesia—Fludarabine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Cromoglicic acid—Hallucination—Carmustine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Cromoglicic acid—Hypoaesthesia—Carmustine—lymphatic system cancer	0.0041	0.0041	CcSEcCtD
Cromoglicic acid—Dyspnoea—Fludarabine—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Cromoglicic acid—Dyspepsia—Fludarabine—lymphatic system cancer	0.00403	0.00403	CcSEcCtD
Cromoglicic acid—Fatigue—Fludarabine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Cromoglicic acid—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Cromoglicic acid—Hallucination—Vincristine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Cromoglicic acid—Pain—Fludarabine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Cromoglicic acid—Constipation—Fludarabine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Cromoglicic acid—Vasculitis—Methotrexate—lymphatic system cancer	0.00389	0.00389	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Teniposide—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Cromoglicic acid—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Cromoglicic acid—Anaemia—Bleomycin—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00377	0.00377	CcSEcCtD
Cromoglicic acid—Asthenia—Teniposide—lymphatic system cancer	0.00373	0.00373	CcSEcCtD
Cromoglicic acid—Malaise—Bleomycin—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Cromoglicic acid—Body temperature increased—Fludarabine—lymphatic system cancer	0.00362	0.00362	CcSEcCtD
Cromoglicic acid—Erythema—Carmustine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Cromoglicic acid—Cough—Bleomycin—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Cromoglicic acid—Diarrhoea—Teniposide—lymphatic system cancer	0.00356	0.00356	CcSEcCtD
Cromoglicic acid—Chest pain—Bleomycin—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Cromoglicic acid—Myalgia—Bleomycin—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Cromoglicic acid—Discomfort—Bleomycin—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Cromoglicic acid—Oedema—Bleomycin—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Cromoglicic acid—Erythema—Mitoxantrone—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Cromoglicic acid—Anaemia—Carmustine—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Cromoglicic acid—Asthenia—Fludarabine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Cromoglicic acid—Rash—Teniposide—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Cromoglicic acid—Dermatitis—Teniposide—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Cromoglicic acid—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00327	0.00327	CcSEcCtD
Cromoglicic acid—Headache—Teniposide—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Cromoglicic acid—Anaemia—Vincristine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Cromoglicic acid—Photosensitivity—Methotrexate—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Cromoglicic acid—Hypotension—Bleomycin—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Cromoglicic acid—Diarrhoea—Fludarabine—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Cromoglicic acid—Convulsion—Carmustine—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Cromoglicic acid—Nausea—Teniposide—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Cromoglicic acid—Anaemia—Mitoxantrone—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Cromoglicic acid—Vertigo—Vincristine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Cromoglicic acid—Chest pain—Carmustine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Cromoglicic acid—Myalgia—Carmustine—lymphatic system cancer	0.00305	0.00305	CcSEcCtD
Cromoglicic acid—Anxiety—Carmustine—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Cromoglicic acid—Paraesthesia—Bleomycin—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Cromoglicic acid—Malaise—Mitoxantrone—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Cromoglicic acid—Dyspnoea—Bleomycin—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Cromoglicic acid—Convulsion—Vincristine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Cromoglicic acid—Oedema—Carmustine—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Cromoglicic acid—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Cromoglicic acid—Myalgia—Vincristine—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Cromoglicic acid—Cough—Mitoxantrone—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Cromoglicic acid—Convulsion—Mitoxantrone—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Cromoglicic acid—Rash—Fludarabine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Cromoglicic acid—Dermatitis—Fludarabine—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Cromoglicic acid—Pain—Bleomycin—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Cromoglicic acid—Headache—Fludarabine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Cromoglicic acid—Tachycardia—Carmustine—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Cromoglicic acid—Myalgia—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cromoglicic acid—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cromoglicic acid—Chest pain—Mitoxantrone—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Cromoglicic acid—Anxiety—Mitoxantrone—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Cromoglicic acid—Lethargy—Methotrexate—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Cromoglicic acid—Discomfort—Mitoxantrone—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Cromoglicic acid—Oedema—Vincristine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Cromoglicic acid—Hypotension—Carmustine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Cromoglicic acid—Oedema—Mitoxantrone—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Cromoglicic acid—Nausea—Fludarabine—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Cromoglicic acid—Urticaria—Bleomycin—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Cromoglicic acid—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Cromoglicic acid—Body temperature increased—Bleomycin—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Cromoglicic acid—Insomnia—Carmustine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Cromoglicic acid—Irritability—Methotrexate—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Cromoglicic acid—Paraesthesia—Carmustine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Cromoglicic acid—Mood swings—Methotrexate—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Cromoglicic acid—Hypotension—Vincristine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Cromoglicic acid—Dyspnoea—Carmustine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Cromoglicic acid—Somnolence—Carmustine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Cromoglicic acid—Hypotension—Mitoxantrone—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Cromoglicic acid—Insomnia—Vincristine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Cromoglicic acid—Paraesthesia—Vincristine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Cromoglicic acid—Constipation—Carmustine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Cromoglicic acid—Pain—Carmustine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Cromoglicic acid—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Cromoglicic acid—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Cromoglicic acid—Somnolence—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Cromoglicic acid—Fatigue—Vincristine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Cromoglicic acid—Asthenia—Bleomycin—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Cromoglicic acid—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0024	0.0024	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Cromoglicic acid—Constipation—Vincristine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Cromoglicic acid—Pain—Vincristine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Cromoglicic acid—Eosinophilia—Methotrexate—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Cromoglicic acid—Fatigue—Mitoxantrone—lymphatic system cancer	0.00235	0.00235	CcSEcCtD
Cromoglicic acid—Constipation—Mitoxantrone—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Cromoglicic acid—Pain—Mitoxantrone—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Cromoglicic acid—Abdominal pain—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Cromoglicic acid—Body temperature increased—Carmustine—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00229	0.00229	CcSEcCtD
Cromoglicic acid—Pancytopenia—Methotrexate—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Cromoglicic acid—Dysuria—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Cromoglicic acid—Neutropenia—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Cromoglicic acid—Abdominal pain—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Cromoglicic acid—Body temperature increased—Vincristine—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Cromoglicic acid—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Cromoglicic acid—Urticaria—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Carmustine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Cromoglicic acid—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Cromoglicic acid—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Cromoglicic acid—Drowsiness—Methotrexate—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Cromoglicic acid—Rash—Bleomycin—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Cromoglicic acid—Dermatitis—Bleomycin—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Cromoglicic acid—Asthenia—Carmustine—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Cromoglicic acid—Stomatitis—Methotrexate—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Vincristine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Cromoglicic acid—Epistaxis—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cromoglicic acid—Asthenia—Vincristine—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Cromoglicic acid—Diarrhoea—Carmustine—lymphatic system cancer	0.002	0.002	CcSEcCtD
Cromoglicic acid—Nausea—Bleomycin—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Cromoglicic acid—Asthenia—Mitoxantrone—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Cromoglicic acid—Dizziness—Carmustine—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Cromoglicic acid—Diarrhoea—Vincristine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Cromoglicic acid—Pharyngitis—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Cromoglicic acid—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Cromoglicic acid—Dizziness—Vincristine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cromoglicic acid—Rash—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Cromoglicic acid—Dermatitis—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Cromoglicic acid—Headache—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Cromoglicic acid—Tinnitus—Methotrexate—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Cromoglicic acid—Rash—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cromoglicic acid—Dermatitis—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Cromoglicic acid—Headache—Vincristine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Cromoglicic acid—Nausea—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Cromoglicic acid—Rash—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Cromoglicic acid—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Cromoglicic acid—Headache—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Cromoglicic acid—Erythema—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cromoglicic acid—Nausea—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Cromoglicic acid—Dysgeusia—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Cromoglicic acid—Nausea—Mitoxantrone—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Cromoglicic acid—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cromoglicic acid—Anaemia—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Cromoglicic acid—Malaise—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Cromoglicic acid—Vertigo—Methotrexate—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Cromoglicic acid—Cough—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Cromoglicic acid—Convulsion—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Cromoglicic acid—Arthralgia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cromoglicic acid—Chest pain—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cromoglicic acid—Myalgia—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Cromoglicic acid—Discomfort—Methotrexate—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Cromoglicic acid—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Cromoglicic acid—Hypotension—Methotrexate—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Cromoglicic acid—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Cromoglicic acid—Insomnia—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Cromoglicic acid—Paraesthesia—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Cromoglicic acid—Dyspnoea—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Cromoglicic acid—Somnolence—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Cromoglicic acid—Dyspepsia—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Cromoglicic acid—Fatigue—Methotrexate—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cromoglicic acid—Pain—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cromoglicic acid—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cromoglicic acid—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cromoglicic acid—Urticaria—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cromoglicic acid—Abdominal pain—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Cromoglicic acid—Body temperature increased—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Cromoglicic acid—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000999	0.000999	CcSEcCtD
Cromoglicic acid—Asthenia—Methotrexate—lymphatic system cancer	0.000973	0.000973	CcSEcCtD
Cromoglicic acid—Diarrhoea—Methotrexate—lymphatic system cancer	0.000928	0.000928	CcSEcCtD
Cromoglicic acid—Dizziness—Methotrexate—lymphatic system cancer	0.000897	0.000897	CcSEcCtD
Cromoglicic acid—Rash—Methotrexate—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Cromoglicic acid—Dermatitis—Methotrexate—lymphatic system cancer	0.000854	0.000854	CcSEcCtD
Cromoglicic acid—Headache—Methotrexate—lymphatic system cancer	0.000849	0.000849	CcSEcCtD
Cromoglicic acid—Nausea—Methotrexate—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
